FDA Safety over Sequestration (SOS) Bill Introduced in the House

A substantial portion of the budget for the Food and Drug Administration (FDA) is comprised of user fees, collected from the industries that the agency regulates. The FDA spends the money collected from the user fees for specific purposes, such as the expedited review and approval of drugs or medical devices. At present, the user fees are not exempt from the sequester, which went into effect in January of this year. Rep. Anna Eshoo, (D-Calif.), is a lead sponsor of a bipartisan House bill, the FDA Safety over Sequestration (SOS) Act, which would exempt the user fees from sequestration. She stated that “private dollars” should not be sacrificed in the name of policy. Proponents of the Act maintain that applying the sequester to the user fees would stifle medical innovation and patient access to “timely therapies.” The SOS Act has found support amongst prominent medical device groups as well.

To read more click here and here.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s